Myrobalan Therapeutics
Myrobalan Therapeutics is a biotechnology company developing novel oral neurorestorative therapies to repair damage and restore neural function in degenerative CNS conditions. They focus on remyelination and anti-neuroinflammation to address diseases like multiple sclerosis and Alzheimer's. Their approach utilizes highly selective, orally available compounds with superior brain penetration.
Buy Funded Startups lists
Funding Round: Series A
Funding Amount: $24M
Date: 10-Jan-2024
Investors: Co-win Ventures, Guan Zi Equity Investment (Li Shui) Partnership (Limited Partnership), 3E Bioventures Capital, AB Magnitude Ventures Group
Markets: Biotechnology, Therapeutics, Neurology, Health Care, Drug Discovery
HQ: Medford, Massachusetts, United States
Founded: 2021
Website: https://myrotx.com/
LinkedIn: https://www.linkedin.com/company/myrobalantx
Crunchbase: https://www.crunchbase.com/organization/myrobalan-therapeutics
Leave a Comment
Comments
No comments yet.